粒细胞集落刺激因子通过诱导髓源性抑制细胞减轻肾脏缺血再灌注损伤
该研究利用小鼠缺血再灌注损伤模型,发现G-CSF预处理可减轻急性肾功能障碍、组织损伤和肾小管凋亡,并抑制巨噬细胞和T细胞浸润及促炎因子水平,同时增加髓源性抑制细胞(MDSC)浸润。G-CSF后处理也能改善肾功能恢复并减轻第28天肾纤维化。MDSC的过继转移具有保护作用,而清除MDSC则消除G-CSF的保护效应。
要点
- G-CSF预处理或后处理均可减轻小鼠肾脏缺血再灌注损伤。
- G-CSF的保护作用依赖于髓源性抑制细胞的诱导和浸润。
- MDSC通过精氨酸酶-1和活性氧抑制T细胞活化,发挥保护作用。
核心结论
- G-CSF通过诱导肾脏髓源性抑制细胞减轻缺血再灌注后的急性肾损伤和慢性肾纤维化。
- 髓源性抑制细胞和G-CSF在肾缺血再灌注损伤中具有治疗潜力。
研究设计与样本
- 研究采用小鼠缺血再灌注损伤模型,探讨G-CSF是否通过增加髓源性抑制细胞浸润来减轻肾损伤。
主要发现
- G-CSF预处理减轻了急性肾功能障碍、组织损伤和肾小管凋亡。
- G-CSF治疗抑制了肾脏巨噬细胞和T细胞浸润以及IL-6、MCP-1、IL-12、TNF-α和IFN-γ水平,但增加了IL-10、精氨酸酶-1和活性氧水平。
- G-CSF后处理改善了肾功能恢复并减轻了第28天的肾纤维化。
- G-CSF增加了肾脏髓源性抑制细胞(F4/80-CD11b+Gr-1int)浸润,尤其是粒细胞型MDSC(CD11b+Ly6GintLy6Clow)。
- 来自G-CSF处理小鼠的脾脏F4/80-CD11b+Gr-1+细胞显示更高的精氨酸酶-1、IL-10和活性氧水平,并主要通过精氨酸酶-1和活性氧有效抑制体外T细胞活化,其过继转移减轻了肾损伤。
临床怎么用
- G-CSF可能通过诱导MDSC减轻肾缺血再灌注损伤,但需进一步临床研究验证。
- MDSC的过继转移或与G-CSF联合策略可能成为肾缺血再灌注损伤的治疗方向。
局限性
- 研究仅基于小鼠模型,结果能否外推到人类尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Granulocyte colony-stimulating factor (G-CSF) can increase populations of myeloid-derived suppressor cells, innate immune suppressors that play an immunoregulatory role in antitumor immunity. However, the roles of myeloid-derived suppressor cells and G-CSF in renal ischemia-reperfusion injury remain unclear. METHODS: We used mouse models of ischemia-reperfusion injury to investigate whether G-CSF can attenuate renal injury by increasing infiltration of myeloid-derived suppressor cells into kidney tissue. RESULTS: G-CSF treatment before ischemia-reperfusion injury subsequently attenuated acute renal dysfunction, tissue injury, and tubular apoptosis. Additionally, G-CSF treatment suppressed renal infiltration of macrophages and T cells as well as renal levels of IL-6, MCP-1, IL-12, TNF-α, and IFN-γ, but it increased levels of IL-10, arginase-1, and reactive oxygen species. Moreover, administering G-CSF after ischemia-reperfusion injury improved the recovery of renal function and attenuated renal fibrosis on day 28. G-CSF treatment increased renal infiltration of myeloid-derived suppressor cells (F4/80-CD11b+Gr-1int), especially the granulocytic myeloid-derived suppressor cell population (CD11b+Ly6GintLy6Clow); splenic F4/80-CD11b+Gr-1+ cells sorted from G-CSF-treated mice displayed higher levels of arginase-1, IL-10, and reactive oxygen species relative to those from control mice. Furthermore, these splenic cells effectively suppressed in vitro T cell activation mainly through arginase-1 and reactive oxygen species, and their adoptive transfer attenuated renal injury. Combined treatment with anti-Gr-1 and G-CSF showed better renoprotective effects than G-CSF alone, whereas preferential depletion of myeloid-derived suppressor cells by pep-G3 or gemcitabine abrogated the beneficial effects of G-CSF against renal injury. CONCLUSIONS: G-CSF induced renal myeloid-derived suppressor cells, thereby attenuating acute renal injury and chronic renal fibrosis after ischemia-reperfusion injury. These results suggest therapeutic potential of myeloid-derived suppressor cells and G-CSF in renal ischemia-reperfusion injury.
引用
- Yan JJ, Ryu JH, Piao H, et al. Granulocyte Colony-Stimulating Factor Attenuates Renal Ischemia-Reperfusion Injury by Inducing Myeloid-Derived Suppressor Cells. J Am Soc Nephrol. 2020. PMID: 32132198. doi:10.1681/ASN.2019060601
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。